Delivery Order SPE2DR25D2014-SPE2DR26FA0S4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,705.24 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of December 12, 2025. This non-competitive, firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency awarded a delivery order valued at $12,750.90 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. The award, issued on December 5, 2025, with an ultimate completion date of December 8, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,816.75 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhaler medication used in respiratory disease management. This is a firm fixed-price delivery order with no set-aside designation, awarded on November 25, 2025, with an ultimate completion date of November 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $8,521.98 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication, with an ultimate completion date of December 8, 2025. This is a firm fixed-price, non-set-aside competitive award issued to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the products will be performed. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $10,092.48 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication commonly used in respiratory disease management. The contract is a firm fixed-price delivery order with an ultimate completion date of December 10, 2025, and was competitively awarded without any set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $28,879.57 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease management. Issued on November 17, 2025, with an ultimate completion date of November 18, 2025, this firm fixed-price delivery order carries no set-aside designation, indicating it was competitively awarded. The contract is being fulfilled from the company's place of performance in...
- The Defense Logistics Agency awarded a delivery order valued at $7,235.55 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a respiratory medication supplied in a 60-dose inhaler format. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation, issued on December 5, 2025, with completion expected by December 8, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office...
- The Defense Logistics Agency awarded a delivery order valued at $2,826.71 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, issued on July 18, 2025, represents a competitive award with no set-aside designation and is scheduled for completion by July 21, 2025. The product will be delivered to AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $15,954.18 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in 60-dose inhalers. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of September 29, 2025, was competitively awarded with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $1,855.39 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination respiratory medication supplied in a 60-dose inhaler. The contract, awarded on October 31, 2025, with completion targeted for November 3, 2025, was competitively awarded with no set-aside designation. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA0S4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $29,947.68 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation medication used in respiratory disease treatment. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded on December 23, 2025, with an ultimate completion date of December 24, 2025. The award represents a child order under AmerisourceBergen Drug Corp's larger indefinite delivery contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's existing DLA contract serves as a comprehensive global pharmaceutical support vehicle enabling the delivery of specialty medications, brand-name and generic drugs, vaccines, and related medical supplies to support defense healthcare programs worldwide. This delivery order for respiratory medication supports the Defense Health Agency and broader military healthcare operations through the company's established pharmaceutical distribution infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.9k | 12/22/25 |